Truist Financial Corp Sells 59,791 Shares of Haleon plc (NYSE:HLN)

Truist Financial Corp decreased its stake in shares of Haleon plc (NYSE:HLN) by 7.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 753,036 shares of the company’s stock after selling 59,791 shares during the period. Truist Financial Corp’s holdings in Haleon were worth $6,197,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of HLN. Pinnacle Bancorp Inc. lifted its holdings in Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock worth $39,000 after buying an additional 4,267 shares during the period. FinTrust Capital Advisors LLC boosted its position in shares of Haleon by 93.7% during the third quarter. FinTrust Capital Advisors LLC now owns 5,557 shares of the company’s stock valued at $46,000 after purchasing an additional 2,688 shares in the last quarter. NBC Securities Inc. bought a new position in Haleon in the third quarter worth $82,000. Hoxton Planning & Management LLC purchased a new position in Haleon during the fourth quarter valued at $85,000. Finally, Rehmann Capital Advisory Group bought a new stake in shares of Haleon during the 3rd quarter valued at $91,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

HLN has been the subject of several research reports. Argus reissued a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC started coverage on shares of Haleon in a research note on Wednesday, April 17th. They set a “buy” rating for the company. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

Haleon Price Performance

NYSE HLN opened at $8.30 on Friday. Haleon plc has a 52 week low of $7.70 and a 52 week high of $8.98. The firm has a market capitalization of $37.90 billion, a P/E ratio of 27.67, a PEG ratio of 2.18 and a beta of 0.28. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The company has a 50-day moving average price of $8.33 and a 200-day moving average price of $8.29.

Haleon Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be given a dividend of $0.1064 per share. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s payout ratio is currently 70.00%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.